Progress in the development of DNA vaccines against foot-and-mouth disease

References

• Nicolau C, Le Pape A, Soriano P, Fargette F, Juhel MF. In vivo expression of rat insulin after intravenous administration of the liposome-entrapped gene for rat insulin I. Proc. Natl Acad. Sci. USA 80, 1068–1072 (1983).
   PubMed Web of Science ®Google Scholar
• Benvenisty N, Reshef L. Direct introduction of genes into rats and expression of the genes. Proc. Natl Acad. Sci. USA 83, 9551–9555 (1986).
   PubMed Web of Science ®Google Scholar
• Wolff JA, Malone RW, Williams P et al. Direct gene transfer into mouse muscle cells in vivo. Science 247, 1465–1468 (1990).
   PubMed Web of Science ®Google Scholar
• Tang DC, DeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature 356, 152–154 (1992).
   PubMed Web of Science ®Google Scholar
• Robinson HL, Hunt LA, Webster RG. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 11, 957–960 (1993).
   PubMed Web of Science ®Google Scholar
• Ulmer JG, Donnelly JJ, Parker SE et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745–1749 (1993).
   PubMed Web of Science ®Google Scholar
• Wang B, Ugen KE, Srikantan V et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA 90, 4156–4160 (1993).
   PubMed Web of Science ®Google Scholar
• Youmans GP, Youmans AS. Immunogenic activity if a ribosomal fraction obtained from Mycobacterium tuberculosis. J. Bacteriol. 89, 1291–1298 (1965).
   Google Scholar
• Berry LJ, Vennman MR. Cellular Antigens. Nowotny A (Ed.). Springer-Verlag, NY, USA, 3–13 (1972).
   Google Scholar
• Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl Acad. Sci. USA 90, 11478–11482 (1993).
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Klinman DM, Seder R. DNA vaccines: immunology, application, and optimization. Ann. Rev. Immunol. 18, 927–974 (2000).
   PubMed Web of Science ®Google Scholar
• Cichutek K. DNA vaccines: development, standardization and regulation. Intervirology 43, 331–338 (2000).
   PubMed Web of Science ®Google Scholar
• Yankauckas MA, Morrow JE, Parker SE et al. Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing the NP gene. DNA Cell Biol. 12, 771–776 (1993).
   PubMed Web of Science ®Google Scholar
• Wolff JA, Ludtke JJ, Acsadi G, Williams P, Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1, 363–369 (1992).
   PubMedGoogle Scholar
• Klinman DM, Currie D, Gursel I, Verthelyi D. Use of CpG oligodeoxynucleotides as immune adjuvants. Immunol. Rev. 199, 201–216 (2004).
   PubMed Web of Science ®Google Scholar
• Somasundaram C, Takamatsu H, Andréoni C et al. Enhanced protective response and immuno-adjuvant effects of porcine GM-CSF on DNA vaccination of pigs against Aujeszky’s disease virus. Vet. Immunol. Immunopathol. 70, 277–287 (1999).
   PubMed Web of Science ®Google Scholar
• Lodmell DL, Ray NB, Ewalt LC. Gene gun particle-mediated vaccination with plasmid DNA confers protective immunity against rabies virus infection. Vaccine 16, 115–118 (1998).
   PubMed Web of Science ®Google Scholar
• Torres CA, Iwasaki A, Barber BH, Robinson HL. Differential dependence on target site tissue for gene-gun and intramuscular DNA immunisation. J. Virol. 158, 4529–4532 (1997).
   Google Scholar
• Feltquate DM, Heaney S, Webster RG, Robinson HL. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunisation. J. Immunol. 158, 2278–2284 (1997).
   PubMed Web of Science ®Google Scholar
• Elnekave M, Furmanov K, Hovav A-H. Intradermal naked plasmid DNA immunization: mechanisms of action. Expert Rev. Vaccines 10(8), 1169–1181 (2011).
   PubMed Web of Science ®Google Scholar
• Wang B, Ugen KE, Srikantan V et al. Gene inoculation generates immune responses against human immunodeficiency virus type I. Proc. Natl Acad. Sci. USA 90, 4157–4805 (1993).
   Google Scholar
• Schirmbeck R, Bohm W, Ando K, Chisari FV, Reimann J. Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in non-responder mice. J. Virol. 69, 5929–5934 (1995).
   PubMed Web of Science ®Google Scholar
• Kuhrober A, Wild J, Pudollek HP, Chisari FV, Reimann J. DNA vaccination with plasmids encoding the intracellular (HBcAg) or secreted (HBeAg) form of the core protein of hepatitis B virus primes T cell responses to two overlapping Kb- and Kd-restricted epitopes. Int. Immunol. 9, 1203–1212 (1997).
   PubMed Web of Science ®Google Scholar
• Polo JM, Lim B, Govindarajan S, Lai MM. Replication of hepatitis delta virus RNA in mice after intramuscular injection of plasmid DNA. J. Virol. 69, 5203–5207 (1995).
   Google Scholar
• He J, Hoffman SL, Hayes CG. DNA inoculation with a plasmid vector carrying the hepatitis E virus structural protein gene induces immune response in mice. Vaccine 15, 357–362 (1997).
   Google Scholar
• Ghias H, Cai S, Slanina S, Nesburn AB, Wechsler SL. Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge. Antiviral Res. 28, 147–157 (1995).
   Google Scholar
• McClements WL, Armstrong ME, Keys RD, Liu MA. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc. Natl Acad. Sci. USA 93, 11414–11420 (1996).
   PubMed Web of Science ®Google Scholar
• Fynan EF, Robinson HL, Webster RG. Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. DNA Cell Biol. 12, 785–789 (1993).
   PubMedGoogle Scholar
• Montgomery DL, Shiver JW, Leander KR et al. Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors. DNA Cell Biol. 12, 777–783 (1993).
   PubMed Web of Science ®Google Scholar
• Cardoso AI, Blixenkrone-Moller M, Fayolle J, Liu M, Buckland R, Wild TF. Immunization with plasmid DNA encoding for the measles virus hemagglutinin and nucleoprotein leads to humoral and cell-mediated immunity. Virology 225, 293–299 (1996).
   PubMed Web of Science ®Google Scholar
• Fooks AR, Jeevarajah D, Warnes A, Wilkinson GW, Clegg JC. Immunization of mice with plasmid DNA expressing the measles virus nucleoprotein gene. Viral Immunol. 9, 65–71 (1996).
   PubMed Web of Science ®Google Scholar
• Cox GJ, Lamb TJ, Babiuk LA. Bovine herpesvirus-1: immune response in mice and cattle injected with plasmid DNA. J. Virol. 67, 5664–5667 (1993).
   PubMed Web of Science ®Google Scholar
• Romito M, Du Plessis DH, Kleef VM, Van Wyk A, Viljoen GJ. DNA-based immunization of a horse using the VP2 gene of african horse sickness virus. Onderstepoort. J. Vet. Res. 66(2), 139–144 (1999).
   Google Scholar
• Schrijver RS, Langedijk JP, Keil GM, Middel WG, Maris-Veldhuis M, van Oirschot JT. Immunization of cattle with BHV-1 vector vaccine or a DNA vaccine both coding for the G protein of BRSV. Vaccine 15, 1908–1916 (1997).
   PubMed Web of Science ®Google Scholar
• Suradhat S, Yoo D, Babiuk LA, Griebel P, Baca-Estrada ME. DNA immunization with a bovine rotavirus VP4 gene induces a Th1-like immune response in mice. Viral Immunol. 10, 117–127 (1997).
   Google Scholar
• Harpin S, Talbot B, Mbikay M, Elazhary Y. Immune response to vaccination with DNA encoding the bovine viral diarrhea virus major glycoprotein gp53 (E2). FEMS Microbiol. Lett. 146, 229–234 (1997).
   PubMedGoogle Scholar
• Sundaram P, Xiao W, Brandsma JL. Particle-mediated delivery of recombinant expression vectors to rabbit skin induces high-titered polyclonal antisera (and circumvents purification of a protein immunogen). Nucleic Acids Res. 24, 1375–1377 (1996).
   PubMed Web of Science ®Google Scholar
• Triyatni M, Jilbert AR, Qiao M, Miller DS, Burrell CJ. Protective efficacy of DNA vaccines against duck hepatitis B virus infection. J. Virol. 72, 84–94 (1998).
   PubMed Web of Science ®Google Scholar
• Olsen CW, Mc Gregor MW, Dybdahl-Sissoko N et al. Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice. Vaccine 15, 1149–1156 (1997).
   PubMed Web of Science ®Google Scholar
• Ward G, Rieder E, Mason PW. Plasmid DNA encoding replicating foot and mouth disease virus genomes induces antiviral immune response in swine. J. Virol. 71, 7442–7447 (1997).
   PubMedGoogle Scholar
• Anderson ED, Mourich DV, Fahrenkrug SC, LaPatra S, Shepherd J, Leong JA. Genetic immunization of rainbow trout (Oncorhynchus mykiss) against infectious hematopoietic necrosis virus. Mol. Mar. Biol. Biotechnol. 5, 114–122 (1996).
   PubMedGoogle Scholar
• Martins LP, Lau LL, Asano MS, Ahmed R. DNA vaccination against persistent viral infection. J. Virol. 69, 2574–2582 (1995).
   PubMed Web of Science ®Google Scholar
• Gonzalez Armas C, Morello CS, Cranmer LD, Spector DH. DNA immunization confers protection against murine cytomegalovirus infection. J. Virol. 70, 7921–7928 (1996).
   PubMed Web of Science ®Google Scholar
• Sarzotti M, Dean TA, Remington MP, Ly CD, Furth PA, Robbins DS. Induction of cytotoxic T cell responses in newborn mice by DNA immunization. Vaccine 15, 795–797 (1997).
   PubMedGoogle Scholar
• Sakaguchi M, Nakamura H, Sonoda K, Hamada F, Hirai K. Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus. Vaccine 14, 747–752 (1996).
   PubMed Web of Science ®Google Scholar
• Pirzadeh B, Dea S. Immune response in pigs vaccinated with plasmid DNA encoding Orf5 of porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 79, 989–999 (1998).
   PubMedGoogle Scholar
• Monteil M, LePotier MF, Guillotin J, Cariolet R, Houdayer C, Eloit M. Genetic immunization of seronegative one-day-old piglets against pseudorabies induces neutralizing antibodies but not protection and is ineffective in piglets from immune dams. Vet. Res. 27, 443–452 (1996).
   PubMed Web of Science ®Google Scholar
• Xiang ZQ, Spitalnik S, Tran M, Wunner WH, Cheng J, Ertl HC. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 199, 132–140 (1994).
   PubMed Web of Science ®Google Scholar
• Martinez X, Brandt C, Saddallah F et al. DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life. Proc. Natl Acad. Sci. USA 94, 8726–8731 (1997).
   PubMed Web of Science ®Google Scholar
• Robinson HL, Lu S, Mustafa F et al. Simian immunodeficiency virus DNA vaccine trial in macaques. Ann. N Y Acad. Sci. 772, 209–211 (1995).
   Google Scholar
• Haynes JR, McCabe DE, Swain WF, Widera G, Fuller JT. Particle-mediated nucleic acid immunization. J. Biotechnol. 44, 37–42 (1996).
   PubMed Web of Science ®Google Scholar
• Heppell J, Lorenzen N, Lorenzen E, Jensen KE, Wu T, Davis HL. Development of DNA vaccines for fish: vector design, antigen expression and demonstration of efficacy using viral haemorrhagic septicaemia virus as model. Fish Shellfish Immunol. 8, 271–286 (1998).
   Web of Science ®Google Scholar
• Hammond JM, Janse ES, Morrissy CJ et al. A prime-boost vaccination strategy using naked DNA followed by recombinant porcine adenovirus protects pigs from classical swine fever. Vet. Microbiol. 80, 101–119 (2001).
   PubMed Web of Science ®Google Scholar
• Davidson AH, Traub-Dargatz J, Roeheaver R et al. Immunologic responses to West Nile virus in vaccinated and clinically affected horses. J. Am. Vet. Med. Assoc. 226, 240–245 (2005).
   PubMed Web of Science ®Google Scholar
• Garver KA, LaPatra SE, Kurath G. Efficacy of an infectious hematopoietic necrosis (IHN) virus DNA vaccine in Chinook Oncorhynchus tshawytscha and sockeye O. nerka salmon. Dis. Aquat. Org. 64, 13–22 (2005).
   PubMed Web of Science ®Google Scholar
• Bergman PJ, Camps-Palau M, McKnight J et al. Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine 24, 4582–4585 (2006).
   PubMed Web of Science ®Google Scholar
• Thacker EL, Holtkamp D, Khan A, Brown P, Draghia A. Plasmid-mediated growth hormone-releasing hormone efficacy in reducing disease associated with Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus infection. J. Anim. Sci. 84, 733–742 (2006).
   PubMed Web of Science ®Google Scholar
• Doel TR. FMD Vaccines. virus Res. 91, 81–99 (2003).
   PubMed Web of Science ®Google Scholar
• Rodriguez LL, Gay CG. Development of vaccines toward the global control and eradication of foot-and-mouth disease. Expert Rev. Vaccines 10(3), 377–387 (2011).
   PubMed Web of Science ®Google Scholar
• Brown F. Progress and perspectiveness in the development of a foot-and-mouth disease vaccine by recombinant DNA technology. Progr. Vet. Microbiol. Immunol. 3, 59–72 (1987).
   Google Scholar
• Brown F. New approaches to vaccination against foot-and-mouth disease. Vaccine 10, 1022–1026 (1992).
   Google Scholar
• Chinsangaram J, Beard C, Mason PW, Zellner M, Ward G, Grubman MJ. Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins. J. Virol. 72, 4454–4457 (1998).
   PubMedGoogle Scholar
• Beard C, Ward G, Rieder E, Chinsangaram J, Grubman MJ, Mason PW. Development of DNA vaccines for foot and mouth disease evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine. J. Biotechnol. 73, 243–249 (1999).
   PubMed Web of Science ®Google Scholar
• Huang H, Yang Z, Xu Q et al. Recombinant fusion protein and DNA vaccines against foot and mouth disease virus infection in guinea pig and swine. Viral Immunol. 12, 1–8 (1999).
   Google Scholar
• Wong HT, Cheng SCS, Chan EWC et al. Plasmids encoding foot-and-mouth disease virus VP1 epitopes elicited immune responses in mice and swine and protected swine against viral infection. Virology 278, 27–35 (2000).
   PubMed Web of Science ®Google Scholar
• Benvenisti L, Rogel A, Kuznetzova L, Bujanover S, Becker Y, Stram Y. Gene gun mediated DNA vaccination against foot-and-mouth disease virus. Vaccine 19, 3885–3895 (2001).
   PubMed Web of Science ®Google Scholar
• Cedillo-Barron L, Foster-Cuevas M, Belsham G, Lefevre F, Parkhouse M. Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D polymerase. J. Gen. Virol. 82, 1713–1724 (2001).
   PubMed Web of Science ®Google Scholar
• Wong HT, Cheng SCS, Sin WY, Chan EWC, Sheng ZT, Xie Y. A DNA vaccine against foot-and-mouth disease elicits an immune response in swine which is enhanced by co-administration with interleukin-2. Vaccine 20, 2641–2647 (2002).
   PubMed Web of Science ®Google Scholar
• Zhang H-Y, Sun S-H, Gui Y-J et al. Optimising strategy for plasmid DNAs containing multiple-epitopes of foot-and-mouth disease virus by cis-expression with IL-2. Vaccine 26, 769–777 (2008).
   Google Scholar
• Shao HJ, Chen L, Su YB. DNA fragment encoding human IL-1β 163–171 peptide enhances the immune responses elicited in mice by DNA vaccine against foot-and-mouth disease. Vet. Res. Comm. 29, 35–46 (2005).
   Google Scholar
• Su B, Wang J, Wang X et al. The effects of IL-6 and TNF-α as molecular adjuvants on immune responses to FMDV and maturation of dendritic cells by DNA vaccination. Vaccine 26, 5111–5122 (2008).
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang X, Kang Y et al. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus. Vaccine 26, 5135–5144 (2008).
   PubMed Web of Science ®Google Scholar
• Zou Q, Wu B, He X et al. Increasing a robust antigen-specific cytotoxic T lymphocyte response by FMDV DNA vaccination with IL-9 expressing construct. J. Biomed. Biotechnol. 2010, 1–8 (2010).
   Google Scholar
• Mingxiao M, Ningyi J, Juan LH et al. Immunogenecity of plasmid encoding P12A and 3C of FMDV and swine IL-18. Antivir. Res. 76, 59–67 (2007).
   PubMed Web of Science ®Google Scholar
• Xiao C, Jin H, Hu Y et al. Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants. Antivir. Res. 76, 11–20 (2007).
   PubMed Web of Science ®Google Scholar
• Cedillo-Barron L, Foster-Cuevas M, Cook A et al. Immunogenecity of plasmids encoding T and B cell epitopes of foot-and-mouth disease virus (FMDV) in swine. Vaccine 21, 4261–4269 (2003).
   Google Scholar
• Shieh JJ, Liang C-M, Chen C-Y et al. Enhancement of the immunity to foot-and-mouth disease virus by DNA priming and protein boosting immunization. Vaccine 19, 4002–4010 (2001).
   Google Scholar
• Jin H, Kang Y, Xiao C et al. DNA prime followed by protein boost enhances neutralisation and Th1 type immunity against FMDV. Viral Immunol. 18, 539–548 (2005).
   Google Scholar
• Zhang HY, Sun SH, Guo YJ et al. Immune response in mice inoculated with plasmid DNAs containing multiple epitopes of foot and mouth disease virus. Vaccine 21, 4704–4707 (2003).
   Google Scholar
• Borrego B, Fernandez-Pacheco P, Ganges L et al. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses. Vaccine 24, 3889–3899 (2006).
   Google Scholar
• Guo H, Liu Z, Sun S et al. Immune response of guinea pigs vaccinated with DNA vaccine of foot and mouth disease virus O/China99. Vaccine 23, 3236–3242 (2005).
   Google Scholar
• Barfoed AM, Rodriguez F, Therrien D, Borrego B, Sobrino F, Kamstrup S. DNA immunisation with 2C FMDV non-structural protein reveals the presence of an immunodominant CD8+, CTL epitope for Balb/c mice. Antivir. Res. 72, 178–189 (2006).
   Google Scholar
• Jin H, Li Y, Ma Z, Zhang F, Xie Q, Gu D, Wang B. Effect of chemical adjuvants on DNA vaccination. Vaccine 22, 2925–2935 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang S, Guo Y-J, Sun S-H et al. DNA vaccination using bacillus Calmette-Geurin DNA as an adjuvant to enhance the immune response to three kinds of swine diseases. Scand. J. Immunol. 62, 371–377 (2005).
   Google Scholar
• Chen L, Lin T, Zhang H-X, Su Y-B. Immune response to foot and mouth disease DNA vaccines can be enhanced by co injection with the Isatis indigotica extract. Intervirology 48, 207–212 (2005).
   Google Scholar
• Fan H, Tong T, Chen H. Immunisation of DNA vaccine encoding C3d-VP1 fusion enhanced protective immune response against foot-and-mouth disease virus. Virus Genes 35, 347–357 (2007).
   Google Scholar
• Xu H, Zhao G, Huang X et al. CD40-expressing plasmid induces anti-CD40 antibody and enhances immune responses to DNA vaccination. J. Gene Med. 12, 97–106 (2010).
   PubMed Web of Science ®Google Scholar
• Kim S-A, Liang C-M, Cheng I-C et al. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity. J. Gene Med. 8, 1182–1191 (2006).
   Google Scholar
• Niborski V, Li Y, Brennan F et al. Efficacy of particle-based DNA delivery for vaccination of sheep against FMDV. Vaccine 24, 7204–7213 (2006).
   PubMed Web of Science ®Google Scholar
• Li Y, Aggarwal N, Takamatsu H-H, Stirling C, Voyce C, Barnett PV. Enhancing immune responses against a plasmid DNA vaccine encoding a FMDV empty capids from serotype O. Vaccine 24, 4602–4606 (2006).
   PubMed Web of Science ®Google Scholar
• Li Y-G, Tian F-L, Gao F-S, Tang X-S, Xia C. Immune responses generated by Lactobacillus as a carried in DNA immunisation against foot-and-mouth disease virus. Vaccine 25, 902–911 (2007).
   PubMedGoogle Scholar
• Dory D, Remond M, Beven V et al. Pseudorabies virus glycoprotein B can be used to carry foot and mouth disease antigens in DNA vaccination of pigs. Antivir. Res. 81, 217–225 (2009).
   Google Scholar
• Wang KY, Guo YJ, Zhang YL, Lv K, Sun SH. Combined DNA vaccination against three animal viruses elicits decreased immunogenicity of a single plasmid in mice. Vaccine 25, 4429–4436 (2007).
   Google Scholar
• Yang B, Lan X, Li X et al. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5’UTR of foot-and-mouth disease virus can induced both rapid inhibitory effect and specific immune responses in mice. Vaccine 26, 5477–5483 (2008).
   Google Scholar
• Li Y, Stirling C, Denyer M et al. Dramatic improvement in FMD DNA vaccine efficacy and cross-serotype antibody induction in pigs following a protein boost. Vaccine 26, 2647–2656 (2008).
   PubMed Web of Science ®Google Scholar
• Borrego B, Argilaguet JM, Perez-Marin E et al. A DNA vaccine encoding foot-and-mouth disease virus B amd T-cell epitopes targeted to class II swine leukocyte antigens protects pigs against viral challenge. Antivir. Res. 92, 359–363 (2011).
   Google Scholar
• Ganges L, Borrego B, Fernandez-Pacheco P et al. DNA immunisation of pigs with foot-and-mouth disease virus minigenes: from partial protection to disease exacerbation. Vaccine 15, 121–125 (2011).
   Google Scholar
• Lu S. Heterologous prime-boost vaccination. Curr. Opin. Immunol. 21, 346–351 (2009).
   PubMed Web of Science ®Google Scholar
• Kent SJ, Zhao A, Best SJ, Chandler JD, Boyle DB, Ramshaw IA. Enhanced T-cell immunogenicity and protective efficacy of a human immunodeficiency virus type 1 vaccine regimen consisting of consecutive priming with DNA and boosting with recombinant fowlpox virus. J. Virol. 72, 10180–10188 (1998).
   PubMed Web of Science ®Google Scholar
• Amara RR, Villinger F, Altman JD et al. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292, 69–74 (2001).
   PubMed Web of Science ®Google Scholar
• Schneider J, Langermans JA, Gilbert SC et al. A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees. Vaccine 19, 4595–4602 (2001).
   PubMed Web of Science ®Google Scholar
• Rogers WO, Baird JK, Kumar A et al. Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques. Infect. Immun. 69, 5565–5572 (2001).
   PubMed Web of Science ®Google Scholar
• Pancholi P, Lee DH, Liu Q et al. DNA prime/canarypox boost-based immunotherapy of chronic hepatitis B virus infection in a chimpanzee. Hepatology 33, 448–454 (2001).
   PubMed Web of Science ®Google Scholar
• Hel Z, Nacsa J, Tryniszewska E et al. Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and post challenge CD4+ and CD8+ T cell responses. J. Immunol. 169, 4778–4787 (2002).
   PubMed Web of Science ®Google Scholar
• Doria-Rose NA, Pierce CC, Hensel MT et al. Multigene DNA prime-boost vaccines for SHIV89.6P. J. Med. Primatol. 32, 218–228 (2003).
   PubMedGoogle Scholar
• Shiver JW, Fu TM, Chen L et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415, 331–335 (2002).
   PubMed Web of Science ®Google Scholar
• Vinner L, Wee EG, Patel S et al. Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost. J. Gen. Virol. 84, 203–213 (2003).
   Google Scholar
• Skinner MA, Buddle BM, Wedlock DN et al. A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis. Infect. Immunol. 71, 4901–4907 (2003).
   PubMed Web of Science ®Google Scholar
• Toussaint JF, Letellier C, Paquet D, Dispas M, Kerkhofs P. Prime-boost strategies combining DNA and inactivated vaccines confer high immunity and protection in cattle against bovine herpesvirus-1. Vaccine 23, 5073–5081 (2005).
   PubMed Web of Science ®Google Scholar
• Cheevers WP, Snekvik KR, Trujillo JD, Kumpula-McWhirter NM, Pretty On Top KJ, Knowles DP. Prime-boost vaccination with plasmid DNA encoding caprine-arthritis encephalitis lentivirus env and viral SU suppresses challenge virus and development of arthritis. Virology 306, 116–125 (2003).
   PubMed Web of Science ®Google Scholar
• Lopez AM, Hines MT, Palmer GH, Knowles DP, Alperin DC, Hines SA. Analysis of anamnestic immune responses in adult horses and priming in neonates induced by a DNA vaccine expressing the vapA gene of Rhodococcus equi. Vaccine 21, 3815–3825 (2003).
   Google Scholar